Lurasidone for Treating Schizophrenia and Bipolar Depression: A Review of Its Efficacy

Lurasidone is an antipsychotic medication that blocks dopamine D2 and serotonin 5-hydroxy-tryptamine (5-HT)(2A )receptors and affects other serotoninergic and noradrenergic receptors. It has rapid absorption and linear pharmacokinetics. The rates of metabolic syndrome for patients taking lurasidone...

Descripción completa

Detalles Bibliográficos
Autores principales: Tarzian, Martin, Soudan, Majd, Alhajji, Muhammed, Ndrio, Mariana, Fakoya, Adegbenro O
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2023
Materias:
Family/General Practice
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10208134/
https://www.ncbi.nlm.nih.gov/pubmed/37228542
http://dx.doi.org/10.7759/cureus.38071

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10208134/
https://www.ncbi.nlm.nih.gov/pubmed/37228542
http://dx.doi.org/10.7759/cureus.38071

Ejemplares similares